TY  - BOOK
ED  - WHO Expert Committee on Venereal Diseases and Treponematoses
ED  - World Health Organization
TI  - WHO Expert Committee on Venereal Diseases and Treponematoses ‎ : sixth report, meeting held in Geneva from 1 to 7 November 1983
T2  - World Health Organization technical report series ; no. 736
SN  - 9241207361
U1  - 100 SD:610.621 
PY  - 1986///
CY  - Geneva
PB  - World Health Organization
KW  - Sexually Transmitted Diseases
KW  - Treponemal Infections
KW  - Communicable Diseases and their Control
N1  - 1. Introduction -- 2. Definition of the problem -- 3. Development of control pregrammes -- 4. Management of sexually transmitted diseases and intervention strategies -- 5. Primary prevention strategies -- 6. Research priorities -- 7. Recommendations -- 8. Summary -- Annexes
N2  - A review of recent changes in the pattern and spectrum of sexually transmitted diseases and a presentation of guidelines for a more practical approach to their treatment and control. Data on epidemiology, patterns of transmission, clinical manifestations, and available treatments are presented in order to characterize the nature and magnitude of problems linked to specific diseases. Particular attention is given to the difficult clinical problems created by the growing number of second generation pathogens, including Chlamydia trachomatis, the herpes viruses, human papilloma viruses, hepatitis virus B, and the human acquired immunodeficiency virus (‎HIV)‎. The book also explores problems associated with the development of antimicrobial-resistant strains of Neisseria gonorrhoeae and Haemophilus ducreyi, the emergence of demographic trends and new sexual practices supportive to the spread of sexually transmitted diseases, and the alarming increase in the prevalence and severity of related complications, including those with a major impact on maternal and infant morbidity. The most extensive sections of the book offer practical advice on the design and implementation of appropriate measures for treatment and control. The book concludes with a set of recommended therapies for these infections and an example of a protocol for a drug trial to evaluate the effectiveness of regimens for the treatment of gonorrhoea
ER  -